Radiogenomics

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

The term radiogenomics is used in two contexts: either to refer to the study of genetic variation associated with response to radiation (radiation genomics) or to refer to the correlation between cancer imaging features and gene expression (imaging genomics).

The term radiogenomics is used in two contexts: either to refer to the study of genetic variation associated with response to radiation (radiation genomics) or to refer to the correlation between cancer imaging features and gene expression (imaging genomics).

Radiation genomics

In radiation genomics, radiogenomics is used to refer to the study of genetic variation associated with response to radiation therapy. Genetic variation, such as single nucleotide polymorphisms, is studied in relation to a cancer patient's risk of developing toxicity following radiation therapy. It is also used in the context of studying the genomics of tumor response to radiation therapy. One clinical application of radiogenomic principles is the genomic adjusted radiation dose (GARD), which uses tumor gene-expression signatures to estimate radiosensitivity. The term radiogenomics was coined in 2002 by Andreassen et al. (2002) as an analogy to pharmacogenomics, which studies the genetic variation associated with drug responses. See also West et al. (2005) and Bentzen (2006).

The Radiogenomics Consortium

In 2009, a Radiogenomics Consortium (RGC) was established to facilitate and promote multi-centre collaboration of researchers linking genetic variants with response to radiation therapy. The Radiogenomics Consortium is a Cancer Epidemiology Consortium supported by the Epidemiology and Genetics Research Program of the National Cancer Institute of the National Institutes of Health. RGC researchers have completed numerous clinical studies that identified genetic variants associated with radiation toxicities in patients with prostate, breast, lung, head and neck, and other cancers.

Past meetings

2009 - Manchester, UK. Consortium proposed. 2010 - New York, USA. 2011 - London, UK. 2012 - Boston, USA. 2013 - Cambridge (also REQUITE launch), UK. 2014 - Heidelberg, Germany. 2015 - Montpellier, France. 2016 - Maastricht, Netherlands. 2017 - Barcelona, Spain. 2018 - Manchester, UK. 2019 - Rochester, USA. 2020 - Online. 2021 - Online. 2022 - Groningen, Netherlands. 2023 - Manchester, UK. 2024 - Aarhus, Denmark. 2025 - Barcelona, Spain.

Imaging genomics

Radiological images are used to diagnose disease on a large scale: tissue imaging correlates with tissue pathology. The addition of genomic data including DNA microarrays, miRNA, RNA-Seq allows new correlations to be made between cellular genomics and tissue-scale imaging.

See also

Pharmacogenomics Radiation therapy Radiosensitivity

References

Text derived from https://en.wikipedia.org/w/index.php?oldid=1369643437 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001369643437 · captured 1786854100.0 · version history

Cite this page as: encyclopegia.org, “Radiogenomics”, snapshot enwiki-001369643437. https://encyclopegia.org/a/radiogenomics

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.